| 4 |
| GREAT POINT PARTNERS LLC |
| 4.2M |
| $24.9M |
| 0.0% |
| 4.438% |
| 4.70% |
| 5 | JPMORGAN CHASE & CO | 4.4M | $24.5M | -2.3% | 4.584% | 0.00% |
| 6 | BRAIDWELL LP | 4.0M | $23.5M | -0.2% | 4.190% | 0.87% |
| 7 | Siren, L.L.C. | 3.7M | $22.0M | 0.0% | 3.932% | 0.45% |
| 8 | BlackRock, Inc. | 3.6M | $21.3M | +690.3% | 3.805% | 0.00% |
| 9 | Commodore Capital LP | 3.3M | $19.2M | 0.0% | 3.421% | 1.14% |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.8M | $16.2M | 0.0% | 2.895% | 0.02% |
| 11 | Saturn V Capital Management LP | 2.1M | $12.4M | +183.9% | 2.212% | 1.78% |
| 12 | QVT Financial LP | 1.9M | $11.2M | +44.6% | 1.995% | 0.66% |
| 13 | ADAR1 Capital Management, LLC | 1.8M | $10.4M | +179.1% | 1.852% | 0.48% |
| 14 | ARMISTICE CAPITAL, LLC | 1.6M | $9.7M | +8.6% | 1.722% | 0.12% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 1.6M | $9.3M | +200.2% | 1.668% | 0.00% |
| 16 | Affinity Asset Advisors, LLC | 1.5M | $8.6M | -42.9% | 1.541% | 0.39% |
| 17 | STEMPOINT CAPITAL LP | 1.4M | $8.1M | +81.6% | 1.440% | 1.39% |
| 18 | Ikarian Capital, LLC | 1.2M | $7.2M | +2.1% | 1.283% | 0.77% |
| 19 | EcoR1 Capital, LLC | 1.2M | $7.0M | 0.0% | 1.242% | 0.34% |
| 20 | Vestal Point Capital, LP | 1.2M | $6.9M | +129.7% | 1.236% | 0.16% |
| 21 | STATE STREET CORP | 1.0M | $5.9M | +413.8% | 1.054% | 0.00% |
| 22 | Boxer Capital Management, LLC | 900K | $5.3M | 0.0% | 0.947% | 0.40% |
| 23 | VANGUARD CAPITAL MANAGEMENT LLC | 747K | $4.4M | +53.5% | 0.787% | 0.00% |
| 24 | GOLDMAN SACHS GROUP INC | 574K | $3.4M | +275.3% | 0.604% | 0.00% |
| 25 | FMR LLC | 528K | $3.1M | -0.2% | 0.556% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ZURA — a direct measure of their conviction.
| 67.18% |
| +1.39 pp |
| $59M |
| 45% |
| Q4 2024 | 85 | +12% | 65.79% | +8.76 pp | $107M | 29% |
| Q3 2024 | 76 | — | 57.03% | — | $150M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
26 institutions opened new positions in ZURA during Q2 2026, while 21 fully exited. 32 added to existing positions and 39 trimmed.
ZURA institutional ownership rose by 6.70 percentage points quarter-over-quarter, with a net change of +3 holders.
The top 10 institutions account for 63.3% of all reported 13F value in ZURA, and the top 25 account for 89.5%.
Across the largest Immunology Biotech peers, institutional ownership levels are: LKFT (49.6%), YARW (1.2%), RKTO (7.9%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.